+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceuticals Top 5 Emerging Markets Industry Guide - Market Summary, Competitive Analysis and Forecast to 2025

  • ID: 5448548
  • Report
  • August 2021
  • Region: Global
  • 158 Pages
  • MarketLine
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

FEATURED COMPANIES

  • Aurobindo Pharma Ltd
  • EMS Sigma Pharma
  • Hypera SA
  • Lupin Ltd
  • Novartis AG
  • Pfizer Inc.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Emerging 5 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights


  • These countries contributed $223.0 billion to the global pharmaceuticals industry in 2020, with a compound annual growth rate (CAGR) of 10.1% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $368.7 billion in 2025, with a CAGR of 10.6% over the 2020-25 period.
  • Within the pharmaceuticals industry, China is the leading country among the top 5 emerging nations, with market revenues of $169.4 billion in 2020. This was followed by Brazil and India with a value of $23.6 and $21.4 billion, respectively.
  • China is expected to lead the pharmaceuticals industry in the top five emerging nations, with a value of $300.9 billion in 2025, followed by India and Brazil with expected values of $29.3 and $28.3 billion, respectively.

Scope


  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five pharmaceuticals market
  • Leading company profiles reveal details of key pharmaceuticals market players’ emerging five operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the emerging five pharmaceuticals market with five year forecasts
  • Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country

Reasons to Buy


  • What was the size of the emerging five pharmaceuticals market by value in 2020?
  • What will be the size of the emerging five pharmaceuticals market in 2025?
  • What factors are affecting the strength of competition in the emerging five pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the emerging five pharmaceuticals market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aurobindo Pharma Ltd
  • EMS Sigma Pharma
  • Hypera SA
  • Lupin Ltd
  • Novartis AG
  • Pfizer Inc.
1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions

2 Top 5 Emerging Countries Pharmaceuticals
2.1. Industry Outlook

3 Pharmaceuticals in South Africa
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
3.6. Macroeconomic Indicators
3.7. Country data

4 Pharmaceuticals in Brazil
4.1. Market Overview
4.2. Market Data
4.3. Market Segmentation
4.4. Market outlook
4.5. Five forces analysis
4.6. Macroeconomic Indicators

5 Pharmaceuticals in China
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
5.6. Macroeconomic Indicators

6 Pharmaceuticals in India
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
6.6. Macroeconomic Indicators

7 Pharmaceuticals in Mexico
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
7.6. Macroeconomic Indicators

8 Company Profiles
8.1. Adcock Ingram Holdings Ltd
8.2. Aspen Pharmacare Holdings Ltd
8.3. Novartis AG
8.4. Ache Laboratorios Farmaceuticos SA
8.5. Hypera SA
8.6. EMS Sigma Pharma
8.7. Yangtze River Pharmaceutical Group
8.8. Shanghai Pharmaceuticals Holding Co Ltd
8.9. Yunnan Baiyao Group Co Ltd
8.10. Guangzhou Pharmaceutical Holdings Ltd
8.11. Sun Pharmaceutical Industries Ltd
8.12. Lupin Ltd
8.13. Aurobindo Pharma Ltd
8.14. Dr. Reddy's Laboratories Limited
8.15. Sanofi SA
8.16. Pfizer Inc.
8.17. Genomma Lab Internacional SAB de CV

9 Appendix
9.1. Methodology
9.2. About the Publisher

List of Tables
Table 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2016-25
Table 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2016-20
Table 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2020-25
Table 4: South Africa pharmaceuticals market value: $ billion, 2016-20
Table 5: South Africa pharmaceuticals market geography segmentation: $ billion, 2020
Table 6: South Africa pharmaceuticals market share: % share, by value, 2020
Table 7: South Africa pharmaceuticals market value forecast: $ billion, 2020-25
Table 8: South Africa size of population (million), 2016-20
Table 9: South Africa GDP (constant 2005 prices, $ billion), 2016-20
Table 10: South Africa GDP (current prices, $ billion), 2016-20
Table 11: South Africa inflation, 2016-20
Table 12: South Africa consumer price index (absolute), 2016-20
Table 13: South Africa exchange rate, 2016-20
Table 14: Brazil pharmaceuticals market value: $ billion, 2016-20
Table 15: Brazil pharmaceuticals market geography segmentation: $ billion, 2020
Table 16: Brazil pharmaceuticals market share: % share, by value, 2020
Table 17: Brazil pharmaceuticals market value forecast: $ billion, 2020-25
Table 18: Brazil size of population (million), 2016-20
Table 19: Brazil GDP (constant 2005 prices, $ billion), 2016-20
Table 20: Brazil GDP (current prices, $ billion), 2016-20
Table 21: Brazil inflation, 2016-20
Table 22: Brazil consumer price index (absolute), 2016-20
Table 23: Brazil exchange rate, 2016-20
Table 24: China pharmaceuticals market value: $ billion, 2016-20
Table 25: China pharmaceuticals market geography segmentation: $ billion, 2020
Table 26: China pharmaceuticals market share: % share, by value, 2020
Table 27: China pharmaceuticals market value forecast: $ billion, 2020-25
Table 28: China size of population (million), 2016-20
Table 29: China GDP (constant 2005 prices, $ billion), 2016-20
Table 30: China GDP (current prices, $ billion), 2016-20
Table 31: China inflation, 2016-20
Table 32: China consumer price index (absolute), 2016-20
Table 33: China exchange rate, 2016-20
Table 34: India pharmaceuticals market value: $ billion, 2016-20
Table 35: India pharmaceuticals market geography segmentation: $ billion, 2020
Table 36: India pharmaceuticals market share: % share, by value, 2020
Table 37: India pharmaceuticals market value forecast: $ billion, 2020-25
Table 38: India size of population (million), 2016-20
Table 39: India GDP (constant 2005 prices, $ billion), 2016-20
Table 40: India GDP (current prices, $ billion), 2016-20
Table 41: India inflation, 2016-20
Table 42: India consumer price index (absolute), 2016-20
Table 43: India exchange rate, 2016-20
Table 44: Mexico pharmaceuticals market value: $ billion, 2016-20
Table 45: Mexico pharmaceuticals market geography segmentation: $ billion, 2020
Table 46: Mexico pharmaceuticals market share: % share, by value, 2020
Table 47: Mexico pharmaceuticals market value forecast: $ billion, 2020-25
Table 48: Mexico size of population (million), 2016-20
Table 49: Mexico GDP (constant 2005 prices, $ billion), 2016-20
Table 50: Mexico GDP (current prices, $ billion), 2016-20
Table 51: Mexico inflation, 2016-20
Table 52: Mexico consumer price index (absolute), 2016-20
Table 53: Mexico exchange rate, 2016-20
Table 54: Adcock Ingram Holdings Ltd: key facts
Table 55: Adcock Ingram Holdings Ltd: Annual Financial Ratios
Table 56: Adcock Ingram Holdings Ltd: Key Employees
Table 57: Aspen Pharmacare Holdings Ltd: key facts
Table 58: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 59: Aspen Pharmacare Holdings Ltd: Key Employees
Table 60: Novartis AG: key facts
Table 61: Novartis AG: Annual Financial Ratios
Table 62: Novartis AG: Key Employees
Table 63: Novartis AG: Key Employees Continued
Table 64: Ache Laboratorios Farmaceuticos SA: key facts
Table 65: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 66: Hypera SA: key facts
Table 67: Hypera SA: Annual Financial Ratios
Table 68: Hypera SA: Key Employees
Table 69: EMS Sigma Pharma: key facts
Table 70: EMS Sigma Pharma: Key Employees
Table 71: Yangtze River Pharmaceutical Group: key facts
Table 72: Yangtze River Pharmaceutical Group: Key Employees

List of Figures
Figure 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2016-25
Figure 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2016-20
Figure 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2020-25
Figure 4: South Africa pharmaceuticals market value: $ billion, 2016-20
Figure 5: South Africa pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 6: South Africa pharmaceuticals market share: % share, by value, 2020
Figure 7: South Africa pharmaceuticals market value forecast: $ billion, 2020-25
Figure 8: Forces driving competition in the pharmaceuticals market in South Africa, 2020
Figure 9: Drivers of buyer power in the pharmaceuticals market in South Africa, 2020
Figure 10: Drivers of supplier power in the pharmaceuticals market in South Africa, 2020
Figure 11: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Africa, 2020
Figure 12: Factors influencing the threat of substitutes in the pharmaceuticals market in South Africa, 2020
Figure 13: Drivers of degree of rivalry in the pharmaceuticals market in South Africa, 2020
Figure 14: Brazil pharmaceuticals market value: $ billion, 2016-20
Figure 15: Brazil pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 16: Brazil pharmaceuticals market share: % share, by value, 2020
Figure 17: Brazil pharmaceuticals market value forecast: $ billion, 2020-25
Figure 18: Forces driving competition in the pharmaceuticals market in Brazil, 2020
Figure 19: Drivers of buyer power in the pharmaceuticals market in Brazil, 2020
Figure 20: Drivers of supplier power in the pharmaceuticals market in Brazil, 2020
Figure 21: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2020
Figure 22: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2020
Figure 23: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2020
Figure 24: China pharmaceuticals market value: $ billion, 2016-20
Figure 25: China pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 26: China pharmaceuticals market share: % share, by value, 2020
Figure 27: China pharmaceuticals market value forecast: $ billion, 2020-25
Figure 28: Forces driving competition in the pharmaceuticals market in China, 2020
Figure 29: Drivers of buyer power in the pharmaceuticals market in China, 2020
Figure 30: Drivers of supplier power in the pharmaceuticals market in China, 2020
Figure 31: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2020
Figure 32: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2020
Figure 33: Drivers of degree of rivalry in the pharmaceuticals market in China, 2020
Figure 34: India pharmaceuticals market value: $ billion, 2016-20
Figure 35: India pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 36: India pharmaceuticals market share: % share, by value, 2020
Figure 37: India pharmaceuticals market value forecast: $ billion, 2020-25
Figure 38: Forces driving competition in the pharmaceuticals market in India, 2020
Figure 39: Drivers of buyer power in the pharmaceuticals market in India, 2020
Figure 40: Drivers of supplier power in the pharmaceuticals market in India, 2020
Figure 41: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2020
Figure 42: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2020
Figure 43: Drivers of degree of rivalry in the pharmaceuticals market in India, 2020
Figure 44: Mexico pharmaceuticals market value: $ billion, 2016-20
Figure 45: Mexico pharmaceuticals market geography segmentation: % share, by value, 2020
Figure 46: Mexico pharmaceuticals market share: % share, by value, 2020
Figure 47: Mexico pharmaceuticals market value forecast: $ billion, 2020-25
Figure 48: Forces driving competition in the pharmaceuticals market in Mexico, 2020
Figure 49: Drivers of buyer power in the pharmaceuticals market in Mexico, 2020
Figure 50: Drivers of supplier power in the pharmaceuticals market in Mexico, 2020
Figure 51: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2020
Figure 52: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2020
Figure 53: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2020
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Adcock Ingram Holdings Ltd
  • Aspen Pharmacare Holdings Ltd
  • Novartis AG
  • Ache Laboratorios Farmaceuticos SA
  • Hypera SA
  • EMS Sigma Pharma
  • Yangtze River Pharmaceutical Group
  • Shanghai Pharmaceuticals Holding Co Ltd
  • Yunnan Baiyao Group Co Ltd
  • Guangzhou Pharmaceutical Holdings Ltd
  • Sun Pharmaceutical Industries Ltd
  • Lupin Ltd
  • Aurobindo Pharma Ltd
  • Dr. Reddy's Laboratories Limited
  • Sanofi SA
  • Pfizer Inc.
  • Genomma Lab Internacional SAB de CV
Note: Product cover images may vary from those shown